Who invested in Tolera Therapeutics?
Tolera Therapeutics's investors include Triathlon Medical Venture Partners, Southwest Michigan First, Hopen Life Science Ventures and Hopen Therapeutics.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$12Mraised across 6 rounds since 2008, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $250K sold, first sale Sept 2014
No investor was named in the report.
Reported by sec.govSEC filing: $1.1M sold, first sale Sept 2013
Reported by prnewswire.comSEC filing: $5.4M sold, first sale Oct 2012
No investor was named in the report.
Reported by sec.govSEC filing: $1.5M sold, first sale May 2012
No investor was named in the report.
From a historical funding recordSEC filing: $4.1M sold, first sale May 2010
From a historical funding record
From the SEC filings it signed: 1 on the team.
On the board, as filediDonald ParfetDouglas MortonMark OlesnavageSuzette Dutch
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Tolera Therapeutics's investors include Triathlon Medical Venture Partners, Southwest Michigan First, Hopen Life Science Ventures and Hopen Therapeutics.
Tolera Therapeutics has raised $12M across 6 rounds since 2008. One round did not disclose an amount, so the total is a floor.
Tolera Therapeutics's most recent round was a Debt of $250K in Sept 2014.
Tolera Therapeutics's largest round on record is $5.5M (Series B), in Oct 2012.
Tolera Therapeutics's first round on record, in Jun 2008, was backed by Triathlon Medical Venture Partners, Southwest Michigan First and Hopen Therapeutics.
Tolera Therapeutics's latest named round is a Debt, in Sept 2014.
Tolera Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.